spironolactone has been researched along with sirolimus in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Boldyreff, B; Braun, S; Lösel, R; Wehling, M | 1 |
Ji, J; Li, D; Lin, S; Lu, Z; Xu, Z; Yan, T; Zheng, Z | 1 |
Kream, RM; Ming, Y; Stefano, GB; Zhuang, Q | 1 |
1 review(s) available for spironolactone and sirolimus
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for spironolactone and sirolimus
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Aldosterone rapidly activates Src kinase in M-1 cells involving the mineralocorticoid receptor and HSP84.
Topics: Aldosterone; Animals; Blotting, Western; Cell Line; Dose-Response Relationship, Drug; Enzyme Activation; Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Kidney; Mice; Phosphorylation; Precipitin Tests; Receptors, Mineralocorticoid; Sirolimus; Spironolactone; src-Family Kinases; Time Factors; Tyrosine | 2004 |
Spironolactone promotes autophagy via inhibiting PI3K/AKT/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress.
Topics: Autophagy; Autophagy-Related Protein 5; Cell Adhesion; Cell Line; Chromones; Diabetic Nephropathies; Down-Regulation; Humans; Integrin beta1; Microtubule-Associated Proteins; Morpholines; Phosphatidylinositol 3-Kinases; Podocytes; Proto-Oncogene Proteins c-akt; Receptors, Mineralocorticoid; Signal Transduction; Sirolimus; Spironolactone; Stress, Mechanical; TOR Serine-Threonine Kinases; Up-Regulation | 2016 |
Anti-Diabetogenic Properties of Mineralocorticoid Receptor Antagonists: Implications for Enhanced Safety and Efficacy of Post-Transplantation Pharmacotherapies.
Topics: Calcineurin; Calcineurin Inhibitors; Cyclosporine; Diabetes Complications; Diabetes Mellitus; Everolimus; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mineralocorticoid Receptor Antagonists; Sirolimus; Spironolactone; Tacrolimus; Transplantation Tolerance | 2019 |